← FDA Drug Approvals (Drugs@FDA)
ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2013-12-05
Drug application
- FDA Application #
ANDA202912
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE
- Generic name
- ABACAVIR , LAMIVUDINE AND ZIDOVUDINE
- Active ingredients
- ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- LUPIN
- Manufacturer
- Lupin Pharmaceuticals, Inc.
- First approval
- 2013-12-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown